Prevalence of Age-Related Macular Degeneration in the United States

Abstract

The Eye Diseases Prevalence Research Group* Objective: To estimate the prevalence and distribution of age-related macular degeneration (AMD) in the United States by age, race/ethnicity, and gender.Methods: Summary prevalence estimates of drusen 125 µm or larger, neovascular AMD, and geographic atrophy were prepared separately for black and white persons in 5-year age intervals starting at 40 years. The estimated rates were based on a meta-analysis of recent populationbased studies in the United States, Australia, and Europe. These rates were applied to 2000 US Census data and to projected US population figures for 2020 to estimate the number of the US population with drusen and AMD. Results:The overall prevalence of neovascular AMD and/or geographic atrophy in the US population 40 years and older is estimated to be 1.47% (95% confidence interval, 1.38%-1.55%), with 1.75 million citizens having AMD. The prevalence of AMD increased dramatically with age, with more than 15% of the white women older than 80 years having neovascular AMD and/or geographic atrophy. More than 7 million individuals had drusen measuring 125 µm or larger and were, therefore, at substantial risk of developing AMD. Owing to the rapidly aging population, the number of persons having AMD will increase by 50% to 2.95 million in 2020. Age-related macular degeneration was far more prevalent among white than among black persons. Conclusion:Age-related macular degeneration affects more than 1.75 million individuals in the United States. Owing to the rapid aging of the US population, this number will increase to almost 3 million by 2020.

Changes of Drusen Number and Central Retinal Thickness in Age-Related Macular Degeneration Patients Over Two Years

“…According to the World Health organization report from 2004, ARMD is the third cause of blindness in the world (8.7%) 15,16 . What makes the problem of ARMD even more important is longer life expectancy, especially in developed countries, which implies an increase in the number of ARMD patients.…”

Mesenchymal Stem Cell Transplantation for Retinal Degenerations and Dystrophies: Present and Future

“…Age-Related Macular Degeneration is a multifactorial disease caused by genetic predisposition and environmental factors, occurring with a rate of 18% at the age of 50-60 and over 30% at the age of 70 (Friedman et al, 2004). It's the leading cause of irreversible blindness in the western countries and the rate is continuously going up because of the rapid increasing of averaged age (Kolar, 2010).…”

Next-generation sequencing analysis of the ARMS2 gene in Turkish exudative age-related macular degeneration patients

“…Inflammatory molecules (cytokines and chemokines), immune cells (macrophages), and complement proteins are also important in the development and progression of AMD (Friedman et al, 2004;Lim et al, 2012;Schwartz et al, 2012;Cascella et al, 2014;Sobrin and Seddon, 2014).…”